When No One Has an Answer: Rhetorical Questions of an IPF Patient

KLF4 Seen to Lessen Transition of Epithelial Cells of Lung into Fibrosis-promoting State in Animal Study

A factor called Krüpple-like-factor 4, or KLF4, treated lung fibrosis in a mouse model of idiopathic pulmonary fibrosis (IPF) by preventing epithelial cells of the lung from moving into a fibrosis-promoting state, researchers in China report, suggesting its potential as an IPF therapy. The study “Krüpple-like-factor 4 Attenuates Lung…

How Pets Benefit Pulmonary Fibrosis Patients

For those of you who are animal lovers, you probably already know that pets can be remarkable companions through illness, injury, loss or throughout any type of recovery period. There are many testimonials and personal stories online about how pets have helped a patient through chronic illness, injury or even…

Anti-inflammatory Agent Ulinastatin Decreases Pulmonary Fibrosis, Study Shows

An anti-inflammatory agent known as ulinastatin decreases pulmonary fibrosis, and at high doses may protect against lung tissue scarring, a study in rats showed. The research, “Therapeutic effect of ulinastatin on pulmonary fibrosis via downregulation of TGF‑β1, TNF‑α and NF‑κB,” was published in the journal Molecular Medicine Reports.

Understanding Palliative Care

Last week, my husband and I met with a palliative care nurse. A few weeks ago, I shared in another column my frustration with seeking palliative care. Our meeting with this nurse was very helpful. I’ll share what I learned, and I hope it will…

Being a Patient Can Test Our Patience

Everyone diagnosed with a life-threatening disease or chronic illness can have a different experience as a patient. Many factors might cause this, including how involved patients are or want to be in their medical care, the expertise of their physicians, and how rapidly or invasive their disease becomes.